Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Expert Rev Mol Diagn. 2014 Jul;14(6):673-83. doi: 10.1586/14737159.2014.925399. Epub 2014 Jun 10.
Epigenetic alterations have been reported to deregulate the expression of many transcripts, including noncoding RNAs that have no apparent protein-coding capacity. Recently, as the result of numerous studies focused on miRNAs, novel sequencing technologies have made available the transcription profile of the entire human genome. miRNAs as drivers of tumor-suppressive and oncogenic functions have been found to be dysregulated in numerous cancer types. However, the functions of epigenetically regulated genetic elements other than protein-coding genes are still a matter of debate. In this review, the authors focus mainly on describing the epigenetic regulation of miRNAs in cancer. They also discuss the role of miRNAs as potential diagnostic and/or prognostic biomarkers.
表观遗传改变已被报道可使许多转录物的表达失调,包括没有明显蛋白编码能力的非编码 RNA。最近,由于大量专注于 miRNA 的研究,新型测序技术使整个人类基因组的转录谱成为可能。在许多癌症类型中,miRNA 作为肿瘤抑制和致癌功能的驱动子被发现失调。然而,除了蛋白编码基因之外,表观遗传调控的遗传元件的功能仍存在争议。在这篇综述中,作者主要集中于描述 miRNA 在癌症中的表观遗传调控。他们还讨论了 miRNA 作为潜在的诊断和/或预后生物标志物的作用。